1Rensing BJ, Vos J,Smits PC,et al, Coronary restenosis elimination with a sirolimus eluting stent:first European Human experience with 6-mouth angiographic and intra-vascular ultrasonic follow-up [ J ], Eur Heart J. 2001,22 ( 22 ) 2125-2130,.
4Roque M, Cordon-Cardo C, Fuster V, et al. Modulation of apoptosis, proliferation, and p^27 expression in a porciae coronary sngioplasty model [ J ]. A therosclerosis.2000,153 (2) :315-322.
5Fingar DC,Salama S,Tsou C.et al, Mammalia cell size is coatrolled by mTOR and its downstream targets S6KI and 4EBPI/4elF4E[J], Genes Dev,2002.16( 12) :1472-1487.
6Hashemolhosseini S, Nagamine Y, Morley SJ, et al. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclinD1 mRNA and protein stability[ J ]. J Biol Chem, 1998,273 (23) : 14424-14429.
7Beretta L,Gingras AC,Svitkin YV, et al, Rapamycin blocks the phosphorylation of 4E-BPI and inhibits cap-dependent initiation of translation [J ]. EMBO J.1999,15(3 ) :658-664.
8Dumont FJ,Su Q. Mechanism of action of the immunosuppressant rapamycin[J], Life Sci, 1996,58 (5) :373-395.
9Braun-Dullaeus RC, Mann MJ ,Seay U.et al, Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphati-dylinositol 3-kinase and mammalian target of rapamycin[J]. Arterioscler Thromb Vase Biol.2001.21 (7) :1152-1158.
1Nikol S, Hofling B. Regulation of smooth muscle cell proliferation and its possible role in preventiong restenosis postangioplasty [J]. Wien Klin Wochenschr, 1995, 107(13): 379-382.
2Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymercoated stent [J].Circulation,2001, 104: 473-479.
3Galli M, Sommariva L, Prati F, et al. Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for actue myocardial infraction [ J ]. Catheter Cardiovasc Interv, 2001, 53:182-187.
4Rousseau H. Self-expanding endocascular sternt in experimental atherosclerosis: Work in progress [ J ].Radiolgoy,1989, 170: 773.
5kuhn FP. Renal artery stenosis: preliminary results of treatment with the strecker stent [J]. Radiology, 1991, 180(2): 367-370.
6Zider JP. Short and long-term vascuiar tissoe response in the Duke bioabsorbable stent [J] . JACC, 1993, 21 (suppl):439A.
7Suswa T. Biodegradable intracoronary stent in adult dogs [J].JACC, 1993, 21 (suppl): 484A.
8Shin KE, Son JW, Sohn MS, et al. Efficacy of heparincoated sent in early setting of acute myocardial infraction [J]. Catheter Cardiovasc Interv, 2001, 52: 306-312.
9Matsumoto Y, Shimokawa H, Morishige K, et al.Biodegradable intracoronary stent in adult dogs [ J ].Cardiovasc Pharmacoi, 2002, 39 (4): 513-522.
10Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stentcoating releasing hirudin and the prostacyclin analogue iloprost [ J ]. Circulation, 2000, 101(12) : 1453-1458.
